Karyopharm Therapeutics Inc. buy Royal Bank of Canada
Start price
07.08.24
/
50%
€0.72
Target price
07.08.25
€2.75
Performance (%)
0.00%
Price
01.08.24
€0.86
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada is currently unchanged from the start price. This prediction currently runs until 07.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Karyopharm Therapeutics Inc. | 0.00% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.84
03.11.23
03.11.23
€2.80
03.11.24
03.11.24
3.03%
01.08.24
01.08.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.67
03.08.23
03.08.23
€3.65
03.08.24
03.08.24
-54.66%
04.08.24
04.08.24